Peripheral Adropin Application Regulates Nutritional Behavior and Fat Tissue-mediated Energy Metabolism

Abstract

Adropin is a peptide hormone that is involved in food and energy homeostasis and has many metabolic roles. Although previous studies attempted to explain the relation between Adropin and nutritional behavior, there is no strong evidence. In the present study, the effects of peripheral Adropin administration on various signals related to nutritional behavior was investigated in rats at doses of 4 μg/kg and 40 μg/kg by using biochemical and histopathological analyses. It was shown that Adropin reduces feed and water consumption in rats. It was also shown that these effects occur through various neuron groups in the central area by affecting many peripheral signals. Adropin modulates many signals contributing to nutritional behavior.

Keywords

• Adropin,Food intake,Feeding behaviour,Hypothalamus

References

1. 1. Hall KD, Heymsfield SB, Kemnitz JW, Klein S, Schoeller DA, Speakman JR. Energy balance and its components: implications for body weight regulation. Am J Clin Nutr. 2012;95(4):989-94.
2. 2. Elmquist JK, Elias CF, Saper CB. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron. 1999;22(2):221-32.
3. 3. Schwartz MW, Woods SC, Porte D, Jr., Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404(6778):661-71.
4. 4. Rohner-Jeanrenaud F, Nogueiras R. Endocrine control of energy homeostasis. Mol Cell Endocrinol. 2015;418 Pt 1:1-2.
5. 5. Krashes MJ, Shah BP, Madara JC, Olson DP, Strochlic DE, Garfield AS, et al. An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger. Nature. 2014;507(7491):238-42. 6. Kim JD, Leyva S, Diano S. Hormonal regulation of the hypothalamic melanocortin system. Front Physiol. 2014;5:480.
6. 7. Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008;8(6):468-81.
7. 8. Aydin S, Kuloglu T, Aydin S, Eren MN, Yilmaz M, Kalayci M, et al. Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes. Molecular and Cellular Biochemistry. 2013;380(1-2):73-81.
8. 9. Akcilar R, Kocak FE, Simsek H, Akcilar A, Bayat Z, Ece E, et al. Antidiabetic and hypolipidemic effects of adropinin streoptozotocin-induced type 2 diabetic rats. Bratisl Lek Listy. 2016;117(2):100-5.

9. 10. Sayin O, Tokgoz Y, Arslan N. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. J Pediatr Endocrinol Metab. 2014;27(5-6):479-84.
10. 11. Wu L, Fang J, Yuan X, Xiong C, Chen L. Adropin reduces hypoxia/reoxygenation-induced myocardial injury via the reperfusion injury salvage kinase pathway. Exp Ther Med. 2019;18(5):3307-14.
11. 12. Altamimi TR, Gao S, Karwi QG, Fukushima A, Rawat S, Wagg CS, et al. Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency. Metabolism-Clinical and Experimental. 2019;98:37-48.
12. 13. Loewen SP, Ferguson AV. Adropin acts in the rat paraventricular nucleus to influence neuronal excitability. Am J Physiol Regul Integr Comp Physiol. 2017;312(4):R511-R9.
13. 14. Ruge T, Hodson L, Cheeseman J, Dennis AL, Fielding BA, Humphreys SM, et al. Fasted to fed trafficking of Fatty acids in human adipose tissue reveals a novel regulatory step for enhanced fat storage. J Clin Endocrinol Metab. 2009;94(5):1781-8.
14. 15. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51(6):1884-8.
15. 16. William WN, Jr., Ceddia RB, Curi R. Leptin controls the fate of fatty acids in isolated rat white adipocytes. J Endocrinol. 2002;175(3):735-44.
16. 17. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 2002;415(6869):339-43.
17. 18. Woods SC, Seeley RJ. Adiposity signals and the control of energy homeostasis. Nutrition. 2000;16(10):894-902.
18. 19. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, et al. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology. 1992;130(6):3608-16.
19. 20. Konner AC, Janoschek R, Plum L, Jordan SD, Rother E, Ma X, et al. Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab. 2007;5(6):438-49.
20. 21. Bartelt A, Bruns OT, Reimer R, Hohenberg H, Ittrich H, Peldschus K, et al. Brown adipose tissue activity controls triglyceride clearance. Nat Med. 2011;17(2):200-5.
21. 22. Geerling JJ, Boon MR, van der Zon GC, van den Berg SAA, van den Hoek AM, Lombes M, et al. Metformin Lowers Plasma Triglycerides by Promoting VLDL-Triglyceride Clearance by Brown Adipose Tissue in Mice. Diabetes. 2014;63(3):880-91.
22. 23. Lechan RM, Fekete C. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res. 2006;153:209-35.
23. 24. Ishihara H, Mori M, Kobayashi I, Kobayashi S. Intraventricular administration of cyclo(His-Pro), a metabolite of thyrotropin-releasing hormone (TRH), decreases water intake in the rat. Proc Soc Exp Biol Med. 1985;178(4):623-8.
24. 25. Stein LM, Yosten GL, Samson WK. Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19. Am J Physiol Regul Integr Comp Physiol. 2016;310(6):R476-80.
25. 26. Lopez M, Alvarez CV, Nogueiras R, Dieguez C. Energy balance regulation by thyroid hormones at central level. Trends in Molecular Medicine. 2013;19(7):418-27.
26. 27. Alvarez-Crespo M, Csikasz RI, Martinez-Sanchez N, Dieguez C, Cannon B, Nedergaard J, et al. Essential role of UCP1 modulating the central effects of thyroid hormones on energy balance. Molecular Metabolism. 2016;5(4):271-82.
27. 28. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141(11):4255-61.
28. 29. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes. 2002;51(1):124-9.
29. 30. Halatchev IG, Cone RD. Peripheral administration of PYY3-36 produces conditioned taste aversion in mice. Cell Metabolism. 2005;1(3):159-68.
30. 31. Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, et al. Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology. 2004;145(6):2687-95.
31. 32. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, et al. Gut hormone PYY3-36 physiologically inhibits food intake. Nature. 2002;418(6898):650-4.
32. 33. Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, et al. Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab. 2003;88(10):4696-701.